Ismael Mancilla-Herrera

Ismael Mancilla-Herrera

Auto-generated profile, based on publicly available information

Ismael Mancilla-Herrera

Biomedical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2016 in Neuroscience Bulletin
Verified
Journal Article
Closed access
Philippe LeffPhilippe Leff
Philippe Leff
IMIsmael Mancilla-Herrera
Ismael Mancilla-Herrera
MFMónica Flores-Ramos
Mónica Flores-Ramos
CCCarlos Cruz-Fuentes
Carlos Cruz-Fuentes
JRJuan Pablo Reyes-Grajeda
Juan Pablo Reyes-Grajeda
DPDavid Ellioth Pulido-Ascencio
David Ellioth Pulido-Ascencio

Verified
Journal Article
Open access
PDF file
Andrea Olmos-OrtizAndrea Olmos-Ortiz
Andrea Olmos-Ortiz
MFMaría del Pilar Flores-Espinosa
María del Pilar Flores-Espinosa
IMIsmael Mancilla-Herrera
Ismael Mancilla-Herrera
RVRodrigo Vega-Sánchez
Rodrigo Vega-Sánchez
Lorenza DiazLorenza Diaz
Lorenza Diaz
VZVerónica Zaga-Clavellina
Verónica Zaga-Clavellina
During pregnancy, the placenta, the mother and the fetus exploit several mechanisms in order to avoid fetal rejection and to maintain an immunotolerant environment throughout nine months. During this time, immune cells from the fetal and maternal compartments interact to provide an adequate defense in case of an infection and to promote a tolerogenic milieu for the fetus to develop peacefully. Trophoblasts and decidual cells, together with resident natural killer cells, dendritic cells, Hofbauer cells and other macrophages, among other cell types, contribute to the modulation of the uterine environment to sustain a successful pregnancy. In this review, the authors outlined some of the various roles that the innate immune system plays at the maternal–fetal interface. First, the cell populations that are recruited into gestational tissues and their immune mechanisms were examined. In the second part, the Toll–like receptor (TLR)–dependent immune responses at the maternal–fetal interface was summarized, in terms of their specific cytokine/chemokine/antimicrobial peptide expression profiles throughout pregnancy.

8 October 2013 in Immunology & Cell Biology
Verified
Journal Article
Closed access
MEMonica Escamilla‐Tilch
Monica Escamilla‐Tilch
GFGeorgina Filio‐Rodríguez
Georgina Filio‐Rodríguez
RRRosario García Rocha
Rosario García Rocha
IMIsmael Mancilla‐Herrera
Ismael Mancilla‐Herrera
NMNicholas Avrion Mitchison
Nicholas Avrion Mitchison
EVErnesto Antonio Vázquez‐Sánchez
Ernesto Antonio Vázquez‐Sánchez

28 October 2019 in Molecular Human Reproduction
Verified
Journal Article
Open access
PDF file
Andrea Olmos-OrtizAndrea Olmos-Ortiz
Andrea Olmos-Ortiz
MDM Déciga-García
M Déciga-García
EPE Preciado-Martínez
E Preciado-Martínez
LBL Bermejo-Martínez
L Bermejo-Martínez
MFMaría del Pilar Flores-Espinosa
María del Pilar Flores-Espinosa
VZVerónica Zaga-Clavellina
Verónica Zaga-Clavellina
Prolactin (PRL) plays an important role in trophoblast growth, placental angiogenesis and immunomodulation within the feto-maternal interface, where different cell types secrete PRL and express its receptor. During pregnancy, inflammatory signalling is a deleterious event that has been associated with poor fetal outcomes. The placenta is highly responsive to the inflammatory stimulus; however, the actions of PRL in placental immunity and inflammation remain largely unknown. The aim of this study was to evaluate PRL effects on the TLR4/NFkB signalling cascade and associated inflammatory targets in cultured explants from healthy term human placentas. An in utero inflammatory scenario was mimicked using lipopolysaccharides (LPS) from Escherichia coli. PRL significantly reduced LPS-dependent TNF-α, IL-1β and IL-6 secretion and intracellular levels. Mechanistically, PRL prevented LPS-mediated upregulation of TLR-4 expression and NFκB phosphorylation. In conclusion, PRL limited inflammatory responses to LPS in the human placenta, suggesting that this hormone could be critical in inhibiting exacerbated immune responses to infections that could threaten pregnancy outcome. This is the first evidence of a mechanism for anti-inflammatory activity of PRL in the human placenta, acting as a negative regulator of TLR-4/NFkB signaling.

24 May 2023 in Molecular and Cellular Endocrinology
Verified
Journal Article
Open access
MBMextli Y. Bermejo-Haro
Mextli Y. Bermejo-Haro
RCRodrigo T. Camacho-Pacheco
Rodrigo T. Camacho-Pacheco
YBYesenia Brito-Pérez
Yesenia Brito-Pérez
IMIsmael Mancilla-Herrera
Ismael Mancilla-Herrera
During pregnancy, the maternal body undergoes a considerable transformation regarding the anatomy, metabolism, and immune profile that, after delivery, allows for protection and nourishment of the offspring via lactation. Pregnancy hormones are responsible for the development and functionality of the mammary gland for breast milk production, but little is known about how hormones control its immune properties. Breast milk composition is highly dynamic, adapting to the nutritional and immunological needs that the infant requires in the first months of life and is responsible for the main immune modeling of breastfed newborns. Therefore, alterations in the mechanisms that control the endocrinology of mammary gland adaptation for lactation could disturb the properties of breast milk that prepare the neonatal immune system to respond to the first immunologic challenges. In modern life, humans are chronically exposed to endocrine disruptors (EDs), which alter the endocrine physiology of mammals, affecting the composition of breast milk and hence the neonatal immune response. In this review, we provide a landscape of the possible role of hormones in the control of passive immunity transferred by breast milk and the possible effect of maternal exposure to EDs on lactation, as well as their impacts on the development of neonatal immunity.

1 January 2010 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
IWIsabel Wong-Baeza
Isabel Wong-Baeza
MAMarcela Alcántara-Hernández
Marcela Alcántara-Hernández
IMIsmael Mancilla-Herrera
Ismael Mancilla-Herrera
IRItzmel Ramírez-Saldívar
Itzmel Ramírez-Saldívar
LALourdes Andrea Arriaga-Pizano
Lourdes Andrea Arriaga-Pizano
AIArmando Isibasi
Armando Isibasi
The sensing of Pathogen Associated Molecular Patterns (PAMPs) by innate immune receptors, such as Toll-like receptors (TLRs), is the first step in the inflammatory response to pathogens.Entamoeba histolytica, the etiological agent of amebiasis, has a surface molecule with the characteristics of a PAMP. This molecule, which was termed lipopeptidophosphoglycan (LPPG), is recognized through TLR2 and TLR4 and leads to the release of cytokines from human monocytes, macrophages, and dendritic cells; LPPG-activated dendritic cells have increased expression of costimulatory molecules. LPPG activates NKT cells in a CD1d-dependent manner, and this interaction limits amebic liver abscess development. LPPG also induces antibody production, and anti-LPPG antibodies prevent disease development in animal models of amebiasis. Because LPPG is recognized by both the innate and the adaptive immune system (it is a “Pamptigen”), it may be a good candidate to develop a vaccine againstE. histolyticainfection and an effective adjuvant.